Amgen, AstraZeneca strike drug development deal

By Staff Report  /  Monday, April 2nd, 2012  /  Banking & Finance, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen, AstraZeneca strike drug development deal

Amgen has entered a development deal with London-based AstraZeneca to jointly commercialize five anti-inflammation drugs. Under the terms of the agreement announced April 2, AstraZeneca will pay a one-time $50 million payment to Amgen and will be responsible for helping the Thousand Oaks-based biotech giant commercialize its inflammation drug pipeline. The firms said in a Read More →